-
公开(公告)号：US20180289673A1
公开(公告)日：2018-10-11
申请号：US16003850
申请日：2018-06-08
申请人： Hospira, Inc.
IPC分类号： A61K31/4174 , A61L2/00 , A61K47/02 , A61K9/08 , A61P29/00 , A61P25/20 , A61P23/02 , A61K9/00 , A61P9/12 , A61K31/4164 , A61P25/22
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
-
公开(公告)号：US09616049B2
公开(公告)日：2017-04-11
申请号：US15058602
申请日：2016-03-02
申请人： Hospira, Inc.
IPC分类号： A61K9/08 , A61K31/4164 , A61K31/4174 , A61K47/02 , A61L2/00
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
-
公开(公告)号：US20180289674A1
公开(公告)日：2018-10-11
申请号：US16003894
申请日：2018-06-08
申请人： Hospira, Inc.
IPC分类号： A61K31/4174 , A61L2/00 , A61K47/02 , A61K9/08 , A61P9/12 , A61P25/22 , A61P25/20 , A61P23/02 , A61K9/00 , A61K31/4164 , A61P29/00
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
-
公开(公告)号：US08455527B1
公开(公告)日：2013-06-04
申请号：US13678148
申请日：2012-11-15
申请人： Hospira, Inc.
IPC分类号： A61K31/164
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
摘要翻译： 目前公开的主题涉及包含右美托咪定或其药学上可接受的盐的药物组合物，其中所述组合物配制成用于胃肠外给药于受试者的液体，并且其中所述组合物作为预混合物设置在密封容器内。 药物组合物可用于例如患者的围手术期护理或镇静。
-
公开(公告)号：US10016396B2
公开(公告)日：2018-07-10
申请号：US15444932
申请日：2017-02-28
申请人： Hospira, Inc.
IPC分类号： A61K31/4174 , A61K31/4164 , A61K9/08 , A61K47/02 , A61L2/00 , A61K9/00
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
-
公开(公告)号：US20160175285A1
公开(公告)日：2016-06-23
申请号：US15058602
申请日：2016-03-02
申请人： Hospira, Inc.
IPC分类号： A61K31/4174 , A61L2/00 , A61K47/02 , A61K9/08
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
摘要翻译： 目前公开的主题涉及包含右美托咪定或其药学上可接受的盐的药物组合物，其中所述组合物配制成用于胃肠外给药于受试者的液体，并且其中所述组合物作为预混合物设置在密封容器内。 药物组合物可用于例如患者的围手术期护理或镇静。
-
公开(公告)号：US20140155446A1
公开(公告)日：2014-06-05
申请号：US14177008
申请日：2014-02-10
申请人： HOSPIRA, INC.
IPC分类号： A61K9/08 , A61K31/4174
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
摘要翻译： 目前公开的主题涉及包含右美托咪定或其药学上可接受的盐的药物组合物，其中所述组合物配制成用于胃肠外给药于受试者的液体，并且其中所述组合物作为预混合物设置在密封容器内。 药物组合物可用于例如患者的围手术期护理或镇静。
-
公开(公告)号：US20130237576A1
公开(公告)日：2013-09-12
申请号：US13867861
申请日：2013-04-22
申请人： HOSPIRA, INC.
IPC分类号： A61K9/08 , A61K31/4164
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
摘要翻译： 目前公开的主题涉及包含右美托咪定或其药学上可接受的盐的药物组合物，其中所述组合物配制成用于胃肠外给药于受试者的液体，并且其中所述组合物作为预混合物设置在密封容器内。 药物组合物可用于例如患者的围手术期护理或镇静。
-
公开(公告)号：US08436033B1
公开(公告)日：2013-05-07
申请号：US13678260
申请日：2012-11-15
申请人： Hospira, Inc.
IPC分类号： A61K31/164
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
-
公开(公告)号：US20170165235A1
公开(公告)日：2017-06-15
申请号：US15444932
申请日：2017-02-28
申请人： Hospira, Inc.
IPC分类号： A61K31/4174 , A61K9/08 , A61L2/00 , A61K9/00 , A61K47/02
CPC分类号： A61K31/4174 , A61K9/0019 , A61K9/08 , A61K31/4164 , A61K47/02 , A61L2/0023 , A61P9/12 , A61P23/02 , A61P25/20 , A61P25/22 , A61P29/00 , Y10S514/816
摘要： The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation.
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.014 秒)
